G

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 6.056 USD -0.72% Market Closed
Market Cap: 302.8m USD

Net Margin
Genfit SA

-85.8%
Current
-41%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-85.8%
=
Net Income
-39m
/
Revenue
45.4m

Net Margin Across Competitors

No Stocks Found

Genfit SA
Glance View

Market Cap
302.8m USD
Industry
Biotechnology

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company is headquartered in Loos, Hauts-De-France. The company went IPO on 2006-12-19. The firm is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The firm targets a number of therapeutic areas, which includes nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), NASH diagnosis, NASH-induced fibrosis and IL-17 dependent autoimmune diseases. The Company’s research programs develop diversified pipeline of drug candidates, including Elafibranor in NASH, which is in phase III; Elafibranor in PBC, which is in phase II; In-Vitro diagnostic test for NASH and Nitazoxanide in fibrosis, which is still in clinical stage, among others.

GNFT Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-85.8%
=
Net Income
-39m
/
Revenue
45.4m
What is the Net Margin of Genfit SA?

Based on Genfit SA's most recent financial statements, the company has Net Margin of -85.8%.

Back to Top